Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam add-on for positive and negative symptoms of schizophrenia
IRCT20221108056437N1Phase 3Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levetiracetam in schizophrenia (2 arms), sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoint: Occurrence of any medication side effect. Started Jul 2023; status: completed.
02
Drugs
levetiracetam
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20221108056437N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056437N1.